Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 17;29(157):200042.
doi: 10.1183/16000617.0042-2020. Print 2020 Sep 30.

Birt-Hogg-Dubé syndrome

Affiliations

Birt-Hogg-Dubé syndrome

Cécile Daccord et al. Eur Respir Rev. .

Abstract

Birt-Hogg-Dubé syndrome (BHD) is a rare inherited autosomal dominant disorder caused by germline mutations in the tumour suppressor gene FLCN, encoding the protein folliculin. Its clinical expression typically includes multiple pulmonary cysts, recurrent spontaneous pneumothoraces, cutaneous fibrofolliculomas and renal tumours of various histological types. BHD has no sex predilection and tends to manifest in the third or fourth decade of life. Multiple bilateral pulmonary cysts are found on chest computed tomography in >80% of patients and more than half experience one or more episodes of pneumothorax. A family history of pneumothorax is an important clue, which suggests the diagnosis of BHD. Unlike other cystic lung diseases such as lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis, BHD does not lead to progressive loss of lung function and chronic respiratory insufficiency. Renal tumours affect about 30% of patients during their lifetime, and can be multiple and recurrent. The diagnosis of BHD is based on a combination of genetic, clinical and/or skin histopathological criteria. Management mainly consists of early pleurodesis in the case of pneumothorax, periodic renal imaging for tumour detection, and diagnostic work-up in search of BHD in relatives of the index patient.

PubMed Disclaimer

Conflict of interest statement

Provenance: Commissioned article, peer reviewed. Conflict of interest: C. Daccord reports non-financial support from Boehringer-Ingelheim and Roche, outside the submitted work. Conflict of interest: J-M. Good has nothing to disclose. Conflict of interest: M-A. Morren has nothing to disclose. Conflict of interest: O. Bonny has nothing to disclose. Conflict of interest: D. Hohl has nothing to disclose. Conflict of interest: R. Lazor reports personal fees and non-financial support from Boehringer-Ingelheim, and non-financial support from Roche and Vifor, outside the submitted work.

Figures

FIGURE 1
FIGURE 1
Chest computed tomography in Birt–Hogg–Dubé syndrome. a) A few pulmonary cysts of uneven distribution, size and shape in predominantly basal and paramediastinal location (arrows). b) Frontal plane reconstruction showing multiple cysts adjacent to blood vessels, fissures and visceral pleura, with predominantly basal and paramediastinal location (arrows).
FIGURE 2
FIGURE 2
Fibrofolliculomas in Birt–Hogg–Dubé syndrome. Multiple skin-coloured tiny papules of the paranasal area can be seen.
FIGURE 3
FIGURE 3
Abdominal computed tomography scan of a patient with chromophobe renal cell carcinoma after injection of contrast media. The left kidney shows an irregular edge and a homogenous mass indicated by the arrow. The tumour was removed by robot-assisted laparoscopic surgery.
FIGURE 4
FIGURE 4
Example of a chromophobe renal cell carcinoma. a) Macroscopic appearance (scale in centimetres). b) Haematoxylin and Eosin staining (× 400). c) Staining with anti-cytokeratin-7 antibodies (× 100). d) CD10 staining (× 100). All images courtesy of Prof. La Rosa (Lausanne University Hospital, Lausanne, Switzerland)
FIGURE 5
FIGURE 5
Histopathology of a fibrofolliculoma with fibroblast-rich mesenchymal tissue in the whole dermal space (Haematoxylin and Eosin stain, ×100). Copyright of this figure belongs to D. Hohl.

Comment in

  • Alveolar proteinosis of genetic origins.
    Hadchouel A, Drummond D, Abou Taam R, Lebourgeois M, Delacourt C, de Blic J. Hadchouel A, et al. Eur Respir Rev. 2020 Oct 28;29(158):190187. doi: 10.1183/16000617.0187-2019. Print 2020 Dec 31. Eur Respir Rev. 2020. PMID: 33115790 Free PMC article.

References

    1. Johnson SR, Cordier JF, Lazor R, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 2010; 35: 14–26. doi: 10.1183/09031936.00076209 - DOI - PubMed
    1. Brauner MW, Grenier P, Mouelhi MM, et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989; 172: 255–258. doi: 10.1148/radiology.172.1.2787036 - DOI - PubMed
    1. Gupta N, Sunwoo BY, Kotloff RM. Birt–Hogg–Dubé syndrome. Clin Chest Med 2016; 37: 475–486. doi: 10.1016/j.ccm.2016.04.010 - DOI - PubMed
    1. Colombat M, Stern M, Groussard O, et al. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med 2006; 173: 777–780. doi: 10.1164/rccm.200510-1620CR - DOI - PubMed
    1. Zamora AC, White DB, Sykes AM, et al. Amyloid-associated cystic lung disease. Chest 2016; 149: 1223–1233. doi: 10.1378/chest.15-1539 - DOI - PubMed